Paul R. Walker

3.2k citations

124 papers · 2.2k indexed · 1 hit paper · h-index 23

Impact in

Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction

Papers in

Oncology 63
- Cancer Immunotherapy and Biomarkers 32
- Lung Cancer Research Studies 15
- CAR-T cell therapy research 8
Cancer Research 22
- Cancer Genomics and Diagnostics 11
- Breast Cancer Treatment Studies 8

Co-authors: Pierre‐Yves Dietrich Abdul Rafeh Naqash Teresa Parent Frédérick Masson Wilma Di Berardino-Besson Cynthia R. Cherry Thomas Calzascia Aparna Hegde
Journals: Journal of Clinical Oncology (21 papers)Cancer Biotherapy and Radiopharmaceuticals (10 papers)Journal of Thoracic Oncology (8 papers)International Journal of Radiation Oncology*Biology*Physics (7 papers)Frontiers in Oncology (4 papers)
Partner nations: United States United Kingdom France

In The Last Decade

Paul R. Walker

122 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer 2020 · 320 citations

Peers

Countries citing papers authored by Paul R. Walker

Since Specialization

Citations

This map shows the geographic impact of Paul R. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul R. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul R. Walker more than expected).

Fields of papers citing papers by Paul R. Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul R. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul R. Walker. The network helps show where Paul R. Walker may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul R. Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul R. Walker Line = papers co-authored together Paul R. Walker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Energy Dynamics in Dementia & the Neurodegenerative Diseases: A New Causal Paradigm E C Marta Calderón, James A. Thorp, 昌由中本, А. А. Штрауб, (unknown), محمد حامد همدرد, Paul R. Walker, (unknown)	2023	1
2	Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy Frontiers in Oncology ·E. Cambier, Melissa Moey, Paul R. Walker, Abdul Rafeh Naqash, Emily Ezquerro, А С Лапшин	2023	6
3	COVID-19: Energy, Protein Folding & Prion Disease E C Marta Calderón, James A. Thorp, А. А. Штрауб, (unknown), B. Wang, (unknown), Paul R. Walker, (unknown)	2022	1
4	Case Report: Peripheral blood T cells and inflammatory molecules in lung cancer patients with immune checkpoint inhibitor-induced thyroid dysfunction: Case studies and literature review Frontiers in Oncology ·Mona A. Marie, Justin McCallen, Dini Kartika Salsabila, Abdul Rafeh Naqash, Alexander F. Hoffman, Deuk-Hee Jin, Suneetha Amara, Mahvish Muzaffar, Paul R. Walker, Li V. Yang	2022	1
5	Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition Journal for ImmunoTherapy of Cancer ·Abdul Rafeh Naqash, Néstor Alemán-Pérez, Li V. Yang, Mahvish Muzaffar, Mona A. Marie, Justin McCallen, 郁杳一, Darla Liles, Paul R. Walker	2019	30
6	Response Criteria in Solid Tumors (PERCIST/RECIST) and SUVmax in Early-Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy International Journal of Radiation OncologyBiologyPhysics ·B. D. van Niekerk, W. Gibson, I.V. Kruglov, Teresa Parent, Eri Ishihara, Mark Bowling, Hyder Arastu, Carlos E.M. Guarido, Paul R. Walker, Andrew Ju	2016	2
7	Inflammatory TNBC Breast Cancer: Demography and Clinical Outcome in a Large Cohort of Patients With TNBC Clinical Breast Cancer ·Tithi Biswas, Jimmy T. Efird, Alexandra Poulouktsi, Sarah E. James, Paul R. Walker, Timothy M. Zagar	2016	17
8	Important prognostic factors for lung cancer in tobacco predominant Eastern North Carolina: Study based on a single cancer registry Lung Cancer ·Tithi Biswas, Paul R. Walker, Tarun K. Podder, Julian Rosenman, Jimmy T. Efird	2014	5
9	Immune Infiltration of Spontaneous Mouse Astrocytomas Is Dominated by Immunosuppressive Cells from Early Stages of Tumor Development Cancer Research ·Matias Vukovic, Madiha Derouazi, He-Feng Huang, Aleanna Melliza, Wilma Di Berardino-Besson, Frédérick Masson, Sabine Hoepner, Djamel Nettour, Karim Burkhardt, Abhijit Guha, Pierre‐Yves Dietrich, Paul R. Walker	2010	51
10	Pulse Infusion Interleukin-2 with Famotidine and Cyclophosphamide Has Activity in Previously Treated Metastatic Melanoma Cancer Biotherapy and Radiopharmaceuticals ·Walter Quan, Charles Knupp, 승현 이, Paul R. Walker	2010	6
11	High-Dose Intensity Pulse Interleukin-2 with Famotidine Has Activity in Metastatic Melanoma Cancer Biotherapy and Radiopharmaceuticals ·Walter Quan, Paul R. Walker, A. Florsch, 승현 이, Linda A. King, P. Domaradzki, Darla Liles	2008	6
12	Low-Dose Cyclophosphamide and Continuous-Infusion Interleukin-2 with Famotidine in Previously Treated Metastatic Melanoma or Kidney Cancer Cancer Biotherapy and Radiopharmaceuticals ·Walter Quan, 승현 이, Linda A. King, Paul R. Walker	2008	7
13	Activity of Continuous Infusion Plus Pulse Interleukin-2 with Famotidine in Patients with Metastatic Kidney Cancer or Melanoma Previously Treated with Interleukin-2 Cancer Biotherapy and Radiopharmaceuticals ·Walter Quan, Paul R. Walker, 승현 이, Tong Hongzhang, Andy Myers, Vikas Ghai, Fracisco Pardo, Darla Liles	2006	1
14	Continuous Infusion Interleukin-2 and Famotidine in Metastatic Kidney Cancer Cancer Biotherapy and Radiopharmaceuticals ·Walter Quan, Fracisco Pardo, 승현 이, Nawazish A. Khan, Darla Liles, Paul R. Walker	2006	5
15	Correlation Between Development of Pulmonary Edema and Response of Pulmonary Metastases of Metastatic Melanoma and Kidney Cancer to High-Dose Continuous-Infusion Interleukin-2 Cancer Biotherapy and Radiopharmaceuticals ·Walter Quan, Nawazish A. Khan, Tong Hongzhang, W. Chris Taylor, 승현 이, Fracisco Pardo, Paul R. Walker	2005	3
16	Continuous Infusion Interleukin-2 and Antihistamines in Metastatic Kidney Cancer Cancer Biotherapy and Radiopharmaceuticals ·Paul R. Walker, Sadik Khuder, Walter Quan	2005	5
17	Administration of High-Dose Continuous Infusion Interleukin-2 to Patients Age 70 or Over Cancer Biotherapy and Radiopharmaceuticals ·Walter Quan, Tong Hongzhang, Chris Taylor, 승현 이, Fracisco Pardo, Paul R. Walker	2005	14
18	Homing Phenotypes of Tumor-Specific CD8 T Cells Are Predetermined at the Tumor Site by Crosspresenting APCs Immunity ·Thomas Calzascia, Frédérick Masson, Wilma Di Berardino-Besson, Emmanuel Contassot, R Wilmotte, Michel Aurrand‐Lions, Curzio Rüegg, Pierre‐Yves Dietrich, Paul R. Walker	2005	186
19	REHABILITATION IN CHRONIC CONGESTIVE HEART FAILURE:COMPARISONOF BICYCLE TRAINING AND MUSLE ELECTRICAL STIMULATION J.C. Eicher, Petr Dobšák, 利光槇野, Paul R. Walker, Suzette M. Birch, Jean-Françis Maillefert, 이후건, François Brunotte, Jacek Wolf	2004	2
20	Spectroscopie du phosphore en résonance magnétique nucléaire La Revue de Médecine Interne ·P. Kaminsky, J. Leandre, Marc Klein, 张港, Paul R. Walker, Jacques Robert, 井上清子	1991	2

About Paul R. Walker

Paul R. Walker is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Immunology, having authored 124 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (32 papers), Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (15 papers), Immunotherapy and Immune Responses (13 papers), Cancer Genomics and Diagnostics (11 papers), Breast Cancer Treatment Studies (8 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (541 citations), Pulmonary and Respiratory Medicine (558 citations), Genetics (175 citations) and Chemical Health and Safety (9 citations). Paul R. Walker has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Pierre‐Yves Dietrich, Abdul Rafeh Naqash, Teresa Parent, Frédérick Masson, Wilma Di Berardino-Besson, Cynthia R. Cherry, Thomas Calzascia, Aparna Hegde, Jimmy T. Efird and Nitika Sharma. Their work appears in journals such as Journal of Clinical Oncology, Cancer Biotherapy and Radiopharmaceuticals, Journal of Thoracic Oncology, International Journal of Radiation Oncology*Biology*Physics and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact